Studying survivors of nearly lethal suicide attempts: an important strategy in suicide research. by Hawton, K

Cytogenetics of long-term survivors of ETV6-RUNX1 fusion positive acute lymphoblastic leukemia. by Konn, Z, Martineau, M, Bown, N, Richards, S, Swansbury, J, Talley, P, Wright, S, Harrison, C

“…Interphase populations with two fusion signals in 18% of the long-term survivors and 31% of relapsed patients were smaller in the long-term survivors (median, 4% of total cells) than in the relapsed patients (median, 84%). …”

Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study by Sissoko, D, Duraffour, S, Kerber, R, Kolie, J, Beavogui, A, Camara, A, Colin, G, Rieger, T, Oestereich, L, Pályi, B, Wurr, S, Guedj, J, Nguyen, T, Eggo, R, Watson, C, Edmunds, W, Bore, J, Koundouno, F, Cabeza-Cabrerizo, M, Carter, L, Kafetzopoulou, L, Kuisma, E, Michel, J, Patrono, L, Rickett, N, Singethan, K, Rudolf, M, Lander, A, Pallasch, E, Bockholt, S, Rodríguez, E, Di Caro, A, Wölfel, R, Gabriel, M, Gurry, C, Formenty, P, Keïta, S, Malvy, D, Carroll, M, Anglaret, X, Günther, S

“…Using our biostatistical model, we predict that 50% and 90% of male survivors clear Ebola virus RNA from seminal fluid at 115 days (90% prediction interval 72–160) and 294 days (212–399) after disease onset, respectively. …”

Repairing the brain with physical exercise: Cortical thickness and brain volume increases in long-term pediatric brain tumor survivors in response to a structured exercise interven... by Szulc-Lerch, K, Timmons, B, Bouffet, E, Laughlin, S, Medeiros, D, Skocic, J, Lerch, J, Mabbott, D

“…We argue that exercise training should be incorporated into the development of neuro-rehabilitative treatments for long-term pediatric brain tumor survivors and other populations with acquired brain injury. …”

Comprehensive cancer-predisposition gene testing in an adult multiple primary tumor series shows a broad range of deleterious variants and atypical tumor phenotypes by Whitworth, J, Smith, PS, Martin, J-E, West, H, Luchetti, A, Rodger, F, Clark, G, Carss, K, Stephens, J, Stirrups, K, Penkett, C, Mapeta, R, Ashford, S, Megy, K, Shakeel, H, Ahmed, M, Adlard, J, Barwell, J, Brewer, C, Casey, RT, Armstrong, R, Cole, T, Evans, DG, Fostira, F, Greenhalgh, L, Hanson, H, Henderson, A, Hoffman, J, Izatt, L, Kumar, A, Kwong, A, Lalloo, F, Ong, KR, Paterson, J, Park, S-M, Chen-Shtoyerman, R, Searle, C, Side, L, Skytte, A-B, Snape, K, Woodward, ER, Tischkowitz, MD, Maher, ER, Aitman, T, Alachkar, H, Ali, S, Allen, L, Allsup, D, Ambegaonkar, G, Anderson, J, Antrobus, R, Armstrong, R, Arno, G, Arumugakani, G, Ashford, S, Astle, W, Attwood, A, Austin, S, Bacchelli, C, Bakchoul, T, Bariana, TK, Baxendale, H, Bennett, D, Bethune, C, Bibi, S, Bitner-Glindzicz, M, Bleda, M, Boggard, H, Bolton-Maggs, P, Booth, C, Bradley, JR, Brady, A, Brown, M, Browning, M, Bryson, C, Burns, S, Calleja, P, Canham, N, Carmichael, J, Carss, K, Caulfield, M, Chalmers, E, Chandra, A, Chinnery, P, Chitre, M, Church, C, Clement, E, Clements-Brod, N, Clowes, V, Coghlan, G, Collins, P, Cookson, V, Cooper, N, Corris, P, Creaser-Myers, A, Dacosta, R, Daugherty, L, Davies, S, Davis, J, De Vries, M, Deegan, P, Deevi, SVV, Deshpande, C, Devlin, L, Dewhurst, E, Dixon, P, Doffinger, R, Dormand, N, Drewe, E, Edgar, D, Egner, W, Erber, WN, Erwood, M, Erwood, M, Everington, T, Favier, R, Firth, H, Fletcher, D, Flinter, F, Frary, A, Freson, K, Furie, B, Furnell, A, Gale, D, Gardham, A, Gattens, M, Ghali, N, Ghataorhe, PK, Ghurye, R, Gibbs, S, Gilmour, K, Gissen, P, Goddard, S, Gomez, K, Gordins, P, Graf, S, Gräf, S, Greene, D, Greenhalgh, A, Greinacher, A, Grigoriadou, S, Grozeva, D, Hackett, S, Hadinnapola, C, Hague, R, Haimel, M, Halmagyi, C, Hammerton, T, Hart, D, Hayman, G, Heemskerk, JWM, Henderson, R, Hensiek, A, Henskens, Y, Herwadkar, A, Holden, S, Holder, M, Holder, S, Hu, F, Veld, A, Huissoon, A, Humbert, M, Hurst, J, James, R, Jolles, S, Josifova, D, Kazmi, R, Keeling, D, Kelleher, P, Kelly, AM, Kennedy, F, Kiely, D, Kingston, N, Koziell, A, Krishnakumar, D, Kuijpers, TW, Kuijpers, T, Kumararatne, D, Kurian, M, Laffan, MA, Lambert, MP, Allen, HL, Lango-Allen, H, Lawrie, A, Lear, S, Lees, M, Lentaigne, C, Liesner, R, Linger, R, Longhurst, H, Lorenzo, L, Louka, E, Machado, R, Ross, RM, Maclaren, R, Maher, E, Maimaris, J, Mangles, S, Manson, A, Mapeta, R, Markus, HS, Martin, J, Masati, L, Mathias, M, Matser, V, Maw, A, McDermott, E, McJannet, C, Meacham, S, Meehan, S, Megy, K, Mehta, S, Michaelides, M, Millar, CM, Moledina, S, Moore, A, Morrell, N, Mumford, A, Murng, S, Murphy, E, Nejentsev, S, Noorani, S, Nurden, P, Oksenhendler, E, Othman, S, Ouwehand, WH, Ouwehand, WH, Papadia, S, Park, S-M, Parker, A, Pasi, J, Patch, C, Paterson, J, Payne, J, Peacock, A, Peerlinck, K, Penkett, CJ, Pepke-Zaba, J, Perry, D, Perry, DJ, Pollock, V, Polwarth, G, Ponsford, M, Qasim, W, Quinti, I, Rankin, S, Rankin, J, Raymond, FL, Rayner-Matthews, P, Rehnstrom, K, Reid, E, Rhodes, CJ, Richards, M, Richardson, S, Richter, A, Roberts, I, Rondina, M, Rosser, E, Roughley, C, Roy, N, Rue-Albrecht, K, Samarghitean, C, Sanchis-Juan, A, Sandford, R, Santra, S, Sargur, R, Savic, S, Schotte, G, Schulman, S, Schulze, H, Scott, R, Scully, M, Seneviratne, S, Sewell, C, Shamardina, O, Shipley, D, Simeoni, I, Sivapalaratnam, S, Smith, KGC, Sohal, A, Southgate, L, Staines, S, Staples, E, Stark, H, Stauss, H, Stein, P, Stephens, J, Stirrups, K, Stock, S, Suntharalingam, J, Talks, K, Tan, Y, Thachil, J, Thaventhiran, J, Thomas, E, Thomas, M, Thompson, D, Thrasher, A, Tischkowitz, M, Titterton, C, Toh, C-H, Toshner, M, Treacy, C, Trembath, R, Tuna, S, Turek, W, Turro, E, Van Geet, C, Veltman, M, Vogt, J, Von Ziegenweldt, J, Noordegraaf, AV, Wakeling, E, Wanjiku, I, Warner, TQ, Wassmer, E, Watkins, H, Watt, C, Webster, N, Welch, S, Westbury, S, Wharton, J, Whitehorn, D, Wilkins, M, Willcocks, L, Williamson, C, Woods, G, Woods, G, Wort, J, Yeatman, N, Yong, P, Young, T, Yu, P

“…Multiple primary tumors (MPTs) affect a substantial proportion of cancer survivors and can result from various causes, including inherited predisposition. …”

Survival analysis part I: basic concepts and first analyses. by Clark, T, Bradburn, M, Love, S, Altman, D

“…Survival data are generally described and modelled in terms of two related functions, the survivor function and the hazard function. The survivor function represents the probability that an individual survives from the time of origin to some time beyond time t. …”

Snake bites by the jararacucu (Bothrops jararacussu): clinicopathological studies of 29 proven cases in Sao Paulo State, Brazil. by Milani Júnior, R, Jorge, M, de Campos, F, Martins, F, Bousso, A, Cardoso, J, Ribeiro, L, Fan, H, França, F, Sano-Martins, I, Cardoso, D, Ide Fernandez, C, Fernandes, J, Aldred, V, Sandoval, M, Puorto, G, Theakston, R, Warrell, D

“…It has accounted for 0.8% to 10% of series of snake bites in São Paulo State, Brazil. …”

Signaling pathways in NSCLC as a predictor of outcome and response to therapy. by Gupta, A, Soto, D, Feldman, MD, Goldsmith, J, Mick, R, Hahn, S, Machtay, M, Muschel, R, Mckenna, W

“…Of the survivors, 25% were positive for EGFR, 0% for Her-2, and 42% for P-Akt. …”

Treating clinically significant avoidance of public transport following the London bombings? by Handley, R, Salkovskis, P, Ehlers, A

“… BACKGROUND: The present paper describes the cognitive-behavioural approach evolved and adapted to treat survivors of the London bombings experiencing fear and avoidance of public transport (travel phobia). …”

Lactic acidosis and hypoglycaemia in children with severe malaria: pathophysiological and prognostic significance. by Krishna, S, Waller, D, ter Kuile, F, Kwiatkowski, D, Crawley, J, Craddock, C, Nosten, F, Chapman, D, Brewster, D, Holloway, P

“…After treatment, lactate concentrations fell rapidly in survivors but fell only slightly, or rose, in fatal cases. …”

Reactive nitrogen intermediates and outcome in severe adult malaria. by Taylor, A, Day, N, Sinh, D, Loc, P, Mai, T, Chau, T, Phu, N, Hien, T, White, N

“…Seventy-six patients who died from severe malaria were matched for age and sex with 76 survivors from a prospectively studied series of 560 patients. …”

Dose-response relationships for radiation-related heart disease: impact of uncertainties in cardiac dose reconstruction by Ntentas, G, Darby, SC, Aznar, MC, Hodgson, DC, Howell, RM, Maraldo, MV, Ahmed, S, Ng, A, Aleman, BMP, Cutter, DJ

“…<br>MATERIALS/METHODS:<br>We assessed the systematic and random uncertainties in the reconstructed doses for published dose-response relationships for RRHD risk in survivors of HL or CC. Using the same reconstruction methods as were used in the original publications, we reconstructed mean heart doses and, wherever possible, mean left-ventricular doses for an independent case-series of test patients. …”

Dead space estimates may not be independently associated with 28-day mortality in COVID-19 ARDS by Morales-Quinteros, L, Neto, AS, Artigas, A, Blanch, L, Botta, M, Kaufman, DA, Schultz, MJ, Tsonas, AM, Paulus, F, Bos, LD

“…Estimations of wasted ventilation such as the estimated dead space fraction (by Harris–Benedict and direct method) and ventilatory ratio were significantly higher in non-survivors than survivors at baseline and during the following days of mechanical ventilation (p < 0.001). …”

Enhanced perceptual priming for neutral stimuli occurring in a traumatic context: two experimental investigations. by Michael, T, Ehlers, A

“…Dissociation and posttraumatic stress disorder: Two prospective studies of motor vehicle accident survivors. British Journal of Psychiatry, 180, 363-368]. …”

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study. by Fielding, A, Richards, S, Chopra, R, Lazarus, H, Litzow, MR, Buck, G, Durrant, I, Luger, S, Marks, D, Franklin, I, McMillan, A, Tallman, MS, Rowe, J, Goldstone, A

“…In a very highly selected subgroup of patients who were able to receive HSCT after relapse, some were long-term survivors. We conclude from a large, unselected series with mature follow-up that most adults with recurring ALL, whatever their prior treatment, cannot be rescued using currently available therapies. …”

Proresolving mediator profiles in cerebrospinal fluid are linked with disease severity and outcome in adults with tuberculous meningitis by Colas, RA, Nhat, LTH, Thuong, NTT, Gómez, EA, Ly, L, Thanh, HH, Mai, NTH, Phu, NH, Thwaites, GE, Dalli, J

“…CSF proresolving mediator concentrations were also associated with 80-d survival. In survivors, we found a significant increase in proresolving mediator concentrations, including the lipoxygenase 5-derived 13-series resolvin (RvT)2, RvT4, and 15-epi-lipoxin B4, compared with those who died. …”

Porcine or human stentless valves for aortic valve replacement? Results of a 10-year comparative study. by Ali, A, Lim, E, Halstead, J, Ashrafian, H, Ali, Z, Khalpey, Z, Theodorou, P, Chamageorgakis, T, Kumar, P, Jackson, C, Pepper, J

“…Survivors were interviewed by telephone according to a defined protocol. …”

Impact of the first national COVID-19 lockdown on referral of women experiencing domestic violence and abuse in England and Wales by Panovska-Griffiths, J, Szilassy, E, Johnson, M, Dixon, S, De Simoni, A, Wileman, V, Dowrick, A, Emsley, E, Griffiths, C, Barbosa, EC, Feder, G

“…<p><strong>Background</strong><br> The lockdown periods to curb COVID-19 transmission have made it harder for survivors of domestic violence and abuse (DVA) to disclose abuse and access support services. …”

Intravenous magnesium sulfate for the management of severe hand, foot, and mouth disease with autonomic nervous system dysregulation in Vietnamese children: study protocol for a ra... by Qui, P, Khanh, T, Trieu, H, Giang, P, Bich, N, Thoa, L, Nhan, L, Sabanathan, S, Van Doorn, R, Toan, N, Merson, L, Dung, N, Khanh, L, Wolbers, M, Hung, N, Chau, N, Wills, B

“…Secondary endpoints comprise these parameters singly, plus other clinical endpoints including the following: requirement for other inotropic agents; duration of hospitalization; presence of neurological sequelae at discharge in survivors; and neurodevelopmental status assessed 6 months after discharge. …”